Oxford spinout Argonaut looks to hack cancer cells and program them to die
A new Oxford oncology spinout is joining the biotech ranks in the UK’s Golden Triangle.
The brainchild of Nick La Thangue, chair of cancer biology …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
